At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Trial of Methylene Blue Chromoendoscopy in Barrett's Esophagus
In Brief
An observational study for Barrett Esophagus. Completed, enrolled 100 participants across 1 site.
Detailed Summary
This study is being done to: Determine if a temporary dye applied to the esophagus identifies areas of dysplasia (pre-cancer). Determine if certain dye patterns indicate specific grades of dysplasia. Determine if overall endoscopy costs can be reduced with this dye technique. Determine if the dye could allow fewer biopsies to be obtained in the future.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBarrett Esophagus
CountriesUnited States
CollaboratorsAstraZeneca
Timeline
N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2002
First PostedJan 2008
Primary CompletionDec 2009
TodayJul 2026
First PostedJan 7, 2008
Enrollment StartDec 1, 2002
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 7 yearsPosted 18.5 years ago